Bone Metabolism & Mineralization Drugs (M05)
A clinical directory of medications used to manage bone density and mineralization disorders. This guide explores the pharmacology of Bisphosphonates, RANKL inhibitors, and parathyroid hormone analogs used in the treatment of osteoporosis and Paget’s disease. Reviewed by Dr. Ahmad Baker for endocrine and orthopedic precision.
Cal D B12 injections combine Calcium, Vitamin D, and B12 to support bone health, aid teething in infants, and help treat specific types of anemia.
A guide to Bone-Care (Alfacalcidol), a potent vitamin D analog for treating calcium disorders, especially in patients with chronic kidney disease.
Osteonate, containing alendronic acid, is a medication used to treat osteoporosis and prevent fractures. This guide explains how Osteonate works by slowing bone breakdown, its proper usage, and important precautions. Understand when to avoid Osteonate, potential side effects, and the significance of correct dosage and administration. Learn about bone health management, calcium and vitamin D…
Decalcit is a powerful supplement combining calcium, phosphorus, and vitamin D to support bone health in children and adults. Learn about its benefits, proper dosage, and answers to common questions in this comprehensive guide.
Boneimc 4mg/5ml, containing zoledronic acid, treats bone metastases, hypercalcemia, and osteoporosis. Learn its uses, dosage, side effects, and precautions.
Osteozomet is used to treat bone disorders like osteoporosis and hypercalcemia of malignancy. It strengthens bones, reduces calcium levels, and prevents complications.
Sunnyshift is a medication that treats metabolic bone diseases by improving bone density and reducing calcium breakdown. It’s an effective alternative to Zometa®.
Oprasta, an affordable local alternative to ACLASTA®, offers effective bone disorder treatment with the same active ingredient at a lower cost and better accessibility.
Zolebonita offers a cost-effective, locally-manufactured alternative to ACLASTA®, providing quality osteoporosis treatment at an affordable price in Egypt.
Aclasta® is a zoledronic acid infusion for osteoporosis and bone diseases, offering fracture prevention and improved bone health with annual dosing.